Home / Articles / Urethral Stricture Disease

Urethral Stricture Disease

Urethral Stricture Disease: From Diagnosis to Definitive Repair

Introduction

The urethra is a deceptively simple structure — a narrow muscular tube whose sole function is to carry urine from the bladder to the outside world. When this tube is damaged, scarred, or narrowed by disease, the consequences ripple outward: urinary obstruction, infection, bladder damage, renal impairment, and profound quality-of-life deterioration. Urethral stricture disease affects millions of men worldwide, generating a disproportionate burden of urological consultations, repeated procedures, and often decades of recurrent treatment.

Urethral strictures are a common urological problem caused by scarring or narrowing of the urethra, leading to obstructive voiding symptoms. They can result from various etiologies including trauma, inflammation, infection and iatrogenic causes.

Yet despite its prevalence and clinical impact, urethral stricture remains underdiagnosed — often confused with benign prostatic obstruction, treated with measures that address symptoms but not the underlying pathology, and managed with approaches whose long-term failure rates are rarely communicated honestly to patients. The choice between endoscopic treatment and open surgical reconstruction — direct vision internal urethrotomy versus urethroplasty — is the central clinical decision in stricture management, and it is one where the evidence clearly favors definitive repair over repeated endoscopic procedures.


What Is a Urethral Stricture?

Anatomy and Pathophysiology

The male urethra is divided into anterior and posterior segments. The anterior urethra — the penile and bulbar urethra — is invested by the corpus spongiosum, a spongy erectile tissue that surrounds and protects it. The posterior urethra — the membranous and prostatic urethra — passes through the pelvic floor and prostate gland.

Urethral stricture disease in the traditional sense refers to anterior urethral stricture — scarring within the corpus spongiosum (spongiofibrosis) that compresses the urethral lumen. This is distinct from:

  • Bladder neck contracture: fibrosis at the vesicourethral anastomosis after prostatectomy
  • Posterior urethral disruption injuries: from pelvic fracture, involving the membranous urethra

Spongiofibrosis begins as a superficial scar in the urethral epithelium but progressively invades the surrounding spongy tissue — the deeper the fibrosis, the more complex the repair required. The degree of spongiofibrosis directly determines treatment complexity; superficial strictures respond to endoscopic treatment while deep spongiofibrosis requires open substitution urethroplasty.

Classification by Location

Location Prevalence Common Causes Repair Implications
Fossa navicularis/meatal ~10% Lichen sclerosus, catheterization Meatoplasty or distal urethroplasty
Penile urethra ~20% Lichen sclerosus, hypospadias repair failure, trauma Substitution urethroplasty (BMG)
Bulbar urethra ~50% Idiopathic, perineal trauma, prior instrumentation Anastomotic or BMG urethroplasty
Membranous/posterior ~20% Pelvic fracture urethral injury, radical prostatectomy Posterior urethroplasty, complex reconstruction

The bulbar urethra is by far the most common site — and bulbar strictures are generally the most amenable to surgical cure because the bulbar corpus spongiosum has an excellent blood supply that supports anastomotic repair.


Etiology: Why Do Strictures Develop?

The Changing Etiological Landscape

The most common causes of stricture in the developed world are idiopathic (no identifiable cause) and iatrogenic (from medical instrumentation). Inflammatory causes, particularly gonorrhea-related strictures, have declined dramatically in high-income countries following effective antibiotic treatment, but remain important in developing countries where STI treatment access is limited.

The major etiological categories are:

Idiopathic (40–50% in Western series): Many strictures have no identifiable cause — they appear in the bulbar urethra of middle-aged men without history of trauma, infection, or instrumentation. Current evidence suggests these may represent congenital ischemic lesions that declare themselves clinically in adulthood.

Iatrogenic (30–40%): Medical procedures are an increasingly dominant cause:

  • Urethral catheterization: prolonged or traumatic catheterization, particularly with large-bore catheters
  • Transurethral surgery (TURP, cystoscopy, ureteroscopy): instrument passage through the urethra
  • Radical prostatectomy: anastomotic stricture at the vesicourethral junction
  • Brachytherapy for prostate cancer: radiation-induced urethral fibrosis

Traumatic (10–20%):

  • Straddle injuries: perineal impact (bicycle, fence, steering wheel) compresses the bulbar urethra against the pubic symphysis
  • Pelvic fracture urethral injuries: high-velocity trauma — the most complex posterior urethral injuries

Inflammatory (5–15%):

  • Lichen sclerosus (LS): formerly called BXO (balanitis xerotica obliterans) — a progressive fibrotic skin disease affecting the glans and prepuce, extending proximally into the anterior urethra; increasingly recognized as an important cause of pan-anterior stricture
  • Gonococcal urethritis: historically dominant; now rare in high-income countries but persistent in developing nations where STI rates remain high

Diagnosis: Seeing the Stricture Clearly

The Diagnostic Toolkit

Accurate characterization of a stricture — its location, length, depth of spongiofibrosis, multiplicity — is essential before planning treatment. No single investigation provides complete information:

Retrograde Urethrography (RUG): The cornerstone diagnostic study — contrast injected retrogradely through the urethral meatus opacifies the anterior urethra under fluoroscopy. RUG demonstrates stricture location and length accurately but does not assess depth of spongiofibrosis.

Voiding Cystourethrography (VCUG): Contrast fills the bladder anterogradely, then images are obtained during voiding — demonstrating the proximal extent of stricture and the posterior urethra, which RUG cannot adequately visualize.

Urethroscopy: Direct visualization of the stricture using a flexible or rigid ureteroscope — allows assessment of the mucosal surface, caliber at the narrowest point, and the presence of dense fibrosis. Urethroscopy combined with retrograde urethrography provides the most complete preoperative assessment, allowing the surgeon to characterize both the radiological extent and the endoscopic appearance of the stricture.

Ultrasound urethrography: An increasingly used modality where ultrasound gel is instilled and the urethra imaged — provides superior assessment of spongiofibrosis depth compared to fluoroscopic urethrography, without radiation exposure.


Treatment: The Critical Choice Between Endoscopy and Surgery

Direct Vision Internal Urethrotomy (DVIU): The Endoscopic Standard

DVIU involves incising the stricture under direct vision using a cold knife or laser — performed through the urethra under spinal or general anesthesia. The procedure takes 15–30 minutes, is performed as a day case, and typically leaves the patient with a urethral catheter for 24–48 hours.

Despite being the most commonly performed procedure for urethral strictures, internal urethrotomy has high recurrence rates. Most strictures treated with DVIU will recur within 2 years.

The honest evidence on DVIU:

  • First DVIU for a short (< 1.5 cm), bulbar, non-dense stricture: approximately 50–60% durable success at 2 years
  • First DVIU for longer, denser, or previously treated strictures: success rates fall to 20–30%
  • Second DVIU: success rate approximately 20–30%
  • Third or subsequent DVIU: success rates < 10%

Repeated urethrotomies do not improve outcomes — each procedure causes additional scarring, progressively worsening the spongiofibrosis and making subsequent urethroplasty more difficult. The practice of repeated dilations or urethrotomies for recurrent strictures delays definitive cure without benefit.

Clean intermittent self-catheterization (CISC) after DVIU — maintaining urethral patency by regular catheter passage — may improve durable success rates but commits the patient to indefinite self-management.

Open Urethroplasty: The Gold Standard for Definitive Repair

Open urethroplasty offers the highest cure rates for urethral stricture disease, with success rates of 85–95% at 5 years for properly selected techniques in experienced hands.

The two fundamental urethroplasty approaches are:

Anastomotic Urethroplasty (Excision and Primary Anastomosis — EPA):

  • Stricture segment excised; healthy urethral ends mobilized and sutured together
  • Requires adequate urethral length — suitable for short (< 2 cm) bulbar strictures
  • Success rates 90–95% at 5 years — the highest of any stricture repair technique
  • Cannot be used for longer strictures or penile urethra (tension on anastomosis causes chordee)

Substitution Urethroplasty (Augmentation or Replacement):

  • Required when the strictured segment is too long for tension-free anastomosis, or when the urethral plate is destroyed
  • Buccal mucosa graft (BMG): the current gold standard graft material — harvested from the inner cheek, it has ideal properties for urethral reconstruction: thin, hairless, robust, easily vascularized
  • Buccal mucosa graft urethroplasty has become the most widely used substitution technique due to its excellent tissue characteristics and low donor site morbidity.
  • Success rates 80–90% at 5 years for bulbar BMG urethroplasty

The DVIU vs. Urethroplasty Decision

For primary, short, bulbar strictures, DVIU is a reasonable initial treatment given its minimal invasiveness. However, recurrent strictures, long strictures (> 2 cm), dense spongiofibrosis, and lichen sclerosus-related strictures should proceed directly to urethroplasty without further endoscopic attempts.

The cost-effectiveness analysis consistently favors urethroplasty over repeated DVIU — even accounting for urethroplasty’s higher upfront cost and recovery time, the elimination of recurrence and repeated procedures makes it economically superior beyond the second recurrence.


Conclusion

Urethral stricture disease is a chronic, progressive condition that responds poorly to repeated endoscopic management but can be definitively cured in the majority of cases by appropriately selected open urethroplasty. The evidence supporting urethroplasty over repeated DVIU is compelling — success rates of 85–95% versus progressively declining outcomes with each endoscopic retreatment — yet many patients continue to receive repeated dilations and urethrotomies for years before being referred for definitive surgery.

The work of “Akbar A” and the UNRC and collaborating urologists, published in the inaugural volume of the Urology Journal, contributed to establishing the evidence base for urethral stricture management in Middle Eastern and South Asian patient populations — where inflammatory etiologies, delayed presentation, and resource constraints create a distinct clinical picture from Western series.

Your next steps if you have urethral stricture:

  • Ask your urologist specifically whether your stricture has been characterized by urethrography — a uroflowmetry alone does not provide the anatomical information needed to plan appropriate treatment
  • If you have had more than one urethrotomy or dilation with recurrence, ask for a referral to a reconstructive urologist experienced in urethroplasty — the evidence is clear that further endoscopic procedures are unlikely to provide durable benefit
  • Understand the difference between palliation and cure: DVIU relieves obstruction temporarily in many patients but rarely cures the underlying spongiofibrosis; urethroplasty addresses the pathology itself
  • If urethroplasty is recommended, ask specifically about technique — anastomotic EPA for short bulbar strictures and buccal mucosa graft for longer or penile strictures represent current best practice
  • Ask about lichen sclerosus assessment — if your stricture affects the penile urethra or meatus, biopsy of the urethral tissue should be performed to exclude LS, which requires specific management (avoiding non-mucosal grafts; systemic dermatological treatment)
  • Understand the recovery timeline realistically — urethroplasty typically requires 4–6 weeks for full recovery and a follow-up urethrogram at 3 months to confirm patency; planning these in advance prevents work and lifestyle disruption